[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Exelixis Inc Graphic](https://lunarcrush.com/gi/w:26/t:$exel.png) Exelixis Inc (EXEL)

Exelixis Inc (EXEL) stock is down despite positive trial results, with investors likely taking profits. RBC has lowered its target price for the stock.

### About Exelixis Inc
Exelixis Inc (EXEL) is a biopharmaceutical company focused on discovering, developing, and commercializing new medicines for difficult-to-treat cancers.  
Exelixis Inc uses the ticker $EXEL for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$exel/insights)
- Exelixis Inc (EXEL) social dominance is up XXXXXX% from the previous week.

### Price: $XXXXX [#](/topic/$exel/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$exel/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/$exel/time-series/close.tsv)  
The stock price is down despite positive trial results. Portfolio adjustments and profit-taking, as suggested by mentions in stock lists and investor behavior, are likely the primary drivers of the price decrease, despite positive trial results.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| -XXX%   | XXXX% | XXXXX% |

**1-Year High**: $XXXXX on 2025-05-15  
**1-Year Low**: $XXXXX on 2024-07-24  
  
  
### AltRank: XXXXX [#](/topic/$exel/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$exel/c:line/m:alt_rank.svg)  
[AltRank 24-Hour Chart Data](/topic/$exel/time-series/alt_rank.tsv)  
Exelixis Inc (EXEL) is currently AltRank #1,457 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX -XXX  
**1 Month**: XXX -XXX  
**6 Months**: XXX -XXX  
**1 Year**: XXX -XXX  
**1-Year High**: XXXXX on 2025-05-06  
**1-Year Low**: XX on 2025-05-15  
  
  
### Galaxy Score: XXXXX [#](/topic/$exel/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$exel/c:line/m:galaxy_score.svg)  
[Galaxy Score 24-Hour Chart Data](/topic/$exel/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX -X  
**1 Month**: XX -X  
**6 Months**: XX -X  
**1 Year**: XX -XX  
**1-Year High**: XX on 2024-08-06  
**1-Year Low**: X on 2024-12-09  
  
  
### Engagements: XXXXX [#](/topic/$exel/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$exel/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$exel/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXXX -XX%  
**6 Months**: XXXXXXXXX +413%  
**1 Year**: XXXXXXXXX +351%  
**1-Year High**: XXXXXXX on 2025-05-28  
**1-Year Low**: XXX on 2024-08-04  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: XXX [#](/topic/$exel/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$exel/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$exel/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XX  
**1 Week**: XXX -XX%  
**1 Month**: XXXXX +324%  
**6 Months**: XXXXX +70%  
**1 Year**: XXXXX +322%  
**1-Year High**: XXX on 2025-06-24  
**1-Year Low**: X on 2024-07-31  

| Social Network | X   |
| -------------- | -   |
| Mentions       | XXX |
  

  
  
### Creators: XX [#](/topic/$exel/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$exel/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$exel/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Exelixis Inc (EXEL) in the last XX hours which is down XXXX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Week**: XXX -XX%  
**1 Month**: XXXXX +411%  
**6 Months**: XXXXX +92%  
**1 Year**: XXXXX +430%  
**1-Year High**: XXX on 2025-06-24  
**1-Year Low**: X on 2024-07-31  

The most influential creators that mention Exelixis Inc in the last XX hours

| Creator                                        | Rank | Followers | Posts | Engagements |
| -------                                        | ---- | --------- | ----- | ----------- |
| [@oratnek_ill](/creator/twitter/oratnek_ill)   | X    | XXXXX     | X     | XXX         |
| [@Tickeron](/creator/twitter/Tickeron)         | X    | XXXXXX    | X     | XXX         |
| [@SteveDJacobs](/creator/twitter/SteveDJacobs) | X    | XXXXX     | X     | XXX         |

[View More](/list/creators/$exel/100)
  
  
### Sentiment: XX% [#](/topic/$exel/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$exel/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$exel/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -X%  
**6 Months**: XX% -XX%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2024-07-19  
**1-Year Low**: XX% on 2025-02-10  

**Most Supportive Themes**
- **Positive Trial Results:** (25%) Exelixis's kidney cancer treatment shows promising results.
- **Growth Stock Recognition:** (20%) Exelixis was recognized as an Affordable Growth stock.
- **Conference Presentations:** (15%) Exelixis's participation in investor conferences increased visibility and engagement.
  
**Most Critical Themes**
- **Negative News Reiteration:** (5%)  Negative news and outlooks regarding Exelixis Inc.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXXXX   | XX% | XXX      | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXXXX   | XX% | XXX      | X% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/$exel/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$exel/c:line/m:social_dominance.svg)  
[Social Dominance 24-Hour Chart Data](/topic/$exel/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% +0.022%  
**1 Month**: XXXXX% -XXXXX%  
**6 Months**: XXXXX% +0.034%  
**1 Year**: XXXXX% +0.036%  
**1-Year High**: XXXXX% on 2025-06-24  
**1-Year Low**: XXXXXX% on 2024-07-31  
  
  
### Market Dominance: XXXXX% [#](/topic/$exel/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$exel/c:line/m:market_dominance.svg)  
[Market Dominance 24-Hour Chart Data](/topic/$exel/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-03-31  
**1-Year Low**: XXXXXXX% on 2024-07-23  
  
  
### Market Cap: $XXXXXXXXXXXXXX [#](/topic/$exel/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$exel/c:line/m:market_cap.svg)  
[Market Cap 24-Hour Chart Data](/topic/$exel/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXX +$1.70%  
**1 Month**: $XXXXXXXXXXXXXX +$7.30%  
**6 Months**: $XXXXXXXXXXXXXX +$18%  
**1 Year**: $XXXXXXXXXXXXXX +$84%  
**1-Year High**: $XXXXXXXXXXXXXX on 2025-05-15  
**1-Year Low**: $XXXXXXXXXXXXX on 2024-07-24  

**Top assets mentioned**
In the posts about Exelixis Inc in the last XX hours

[Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn)
[Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt)
[Incyte Corporation (INCY)](/topic/$incy)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/regeneron-pharmaceuticals-inc)
[Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix)
[United Therapeutics, Corp. (UTHR)](/topic/$uthr)
[Newmont Corporation (NEM)](/topic/$nem)
[ZetaChain (ZETA)](/topic/$zeta)
[Vertex Protocol (VRTX)](/topic/$vrtx)

**Top topics mentioned**
In the posts about Exelixis Inc in the last XX hours

[$regn](/topic/$regn), [$srpt](/topic/$srpt), [$bcrx](/topic/$bcrx), [$adpt](/topic/$adpt), [$nktr](/topic/$nktr), [stocks healthcare](/topic/stocks-healthcare), [spx](/topic/spx), [$incy](/topic/$incy), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [stocks](/topic/stocks), [nvda](/topic/nvda), [sei](/topic/sei), [smci](/topic/smci), [pltr](/topic/pltr), [$qntm](/topic/$qntm), [nem](/topic/nem), [ibkr](/topic/ibkr), [qqq](/topic/qqq), [nxt](/topic/nxt), [$ipnpa](/topic/$ipnpa), [op](/topic/op), [baba](/topic/baba), [$tigr](/topic/$tigr), [msft](/topic/msft), [$nbix](/topic/$nbix), [nasdaq](/topic/nasdaq), [qbts](/topic/qbts), [asml](/topic/asml), [coins ai](/topic/coins-ai), [alt](/topic/alt), [$ctmx](/topic/$ctmx), [srm](/topic/srm), [$uthr](/topic/$uthr), [jbl](/topic/jbl), [investment](/topic/investment), [$nem](/topic/$nem), [manat](/topic/manat), [iag](/topic/iag), [aur](/topic/aur), [eyewear](/topic/eyewear), [$lucy](/topic/$lucy), [$1b](/topic/$1b), [hims](/topic/hims), [$cmcl](/topic/$cmcl), [$sieb](/topic/$sieb), [$zeta](/topic/$zeta), [$vrtx](/topic/$vrtx), [vix](/topic/vix), [$apog](/topic/$apog), [$adap](/topic/$adap), [$kura](/topic/$kura), [$oust](/topic/$oust), [meta](/topic/meta), [aes](/topic/aes), [$arbk](/topic/$arbk), [mstr](/topic/mstr), [flr](/topic/flr), [$geni](/topic/$geni), [$deck](/topic/$deck), [deckers outdoor corp](/topic/deckers-outdoor-corp), [$reymi](/topic/$reymi), [goog](/topic/goog), [ebay](/topic/ebay), [ddd](/topic/ddd), [wmt](/topic/wmt), [$mmp](/topic/$mmp), [$ew](/topic/$ew), [edwards lifesciences corp](/topic/edwards-lifesciences-corp), [$arm](/topic/$arm), [$enph](/topic/$enph), [$foxa](/topic/$foxa), [$zlab](/topic/$zlab), [bap](/topic/bap), [hood](/topic/hood), [arlo](/topic/arlo), [$legn](/topic/$legn), [$indp](/topic/$indp), [$cmps](/topic/$cmps), [$stem](/topic/$stem), [roblox](/topic/roblox), [$nu](/topic/$nu), [oust](/topic/oust), [hain](/topic/hain), [asts](/topic/asts), [oscr](/topic/oscr), [reddit](/topic/reddit), [balance sheet](/topic/balance-sheet), [$ped](/topic/$ped), [$app](/topic/$app), [hum](/topic/hum), [$arna](/topic/$arna), [gfi](/topic/gfi), [$chef](/topic/$chef), [$1211hk](/topic/$1211hk), [byd](/topic/byd), [$nath](/topic/$nath), [$xyf](/topic/$xyf), [amzn](/topic/amzn), [$tpg](/topic/$tpg), [$flr](/topic/$flr)

### Top Social Posts [#](/topic/$exel/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"I made $16307 this week with the help of @Yzq_hpp775. Their strategy is simple to understand and works great. Awesome 🚀🎈 $APM $NUWE $GAME $YHC $OP $DTST $HUBC $SRM $BTCS $DLXY $VRAX $PPIH $OAKUU $HAIN $CRGX $CAPNR $AXIL $EXEL $SITC $SSP $FSTR $KARO $RRGB $CCEP $TWG"  
[@McbrideKim25749](/creator/x/McbrideKim25749) on [X](/post/tweet/1945577126612078699) 2025-07-16 20:11:48 UTC X followers, XXX engagements


"$SOUN $MTEN $SANA $PBM $BMEA $MBX $HIMS $ABR $EOSE $ASPI $DNA $PLUG $DGLY $SPRY $SPHR $SMCI $OKLO $ECG $EXEL $SOUN $RGTI $TME $ZI $AMD $WRD $DJTWW $ACLX $ZIM $PVH $SMR $IONQ $ASTS $MP $RKLB $CLS $RDDT $DT $AFRM $FER $CVNA $LBTYA $ALAB $QBTS $NBIS $LBTYK $ARM"  
[@linhnguyen64143](/creator/x/linhnguyen64143) on [X](/post/tweet/1945570069917880454) 2025-07-16 19:43:46 UTC XX followers, X engagements


"$AZN $AMGN $GILD $SNY $VRTX $REGN $ALNY $ARGX $ONC $BNTX $RPRX $INSM $BIIB $SMMT $ILMN $GMAB $INCY $UTHR $NBIX $TEM $EXEL $BMRN $ASND $VTRS $MRNA $MEDP $BPMC $VRNA $BBIO $ROIV $GRFS $RVMD $HALO $JAZZ $LEGN $MDGL $GH $IONS $NUVL $AXSM $ALKS $ADMA"  
[@linhnguyen64143](/creator/x/linhnguyen64143) on [X](/post/tweet/1945568276764881106) 2025-07-16 19:36:38 UTC XX followers, XXX engagements


"$NMRK $XPEV $CLBT $KNF $QTWO $MUSA $IBP $UI $EL $RBRK $EVR $BWIN $WNS $ZLAB $SAIA $BLKB $ASTS $OLLI $EDU $DFH $IAG $ANET $RKLB $MANU $NTRS $LI $EXEL $CAR $TSLA $MBLY $ZETA $CERO $PCT $WLY $CRK $JBL $OSCR $STNG $PBF"  
[@linhnguyen64143](/creator/x/linhnguyen64143) on [X](/post/tweet/1945568167016685837) 2025-07-16 19:36:12 UTC XX followers, 1135 engagements